Target intelligence / Profile preview

Cytochrome c oxidase (yeast mitochondrial) (CIV)

Target
CIV
Molecular classification
Enzyme, Oxidoreductase, Mitochondrial respiratory chain complex
01

Overview

Cytochrome c oxidase (complex IV) is the terminal enzyme of the mitochondrial respiratory chain in yeast. It catalyzes the transfer of electrons from cytochrome c to molecular oxygen, reducing it to water, and couples this process with proton translocation across the inner mitochondrial membrane, contributing to the generation of the proton motive force required for ATP synthesis[2][3][5][6]. The enzyme is a large multi-subunit complex comprising mitochondrially and nuclear-encoded proteins, with a conserved catalytic core (subunits Cox1–3 in yeast) and multiple supernumerary subunits[5][3]. In Saccharomyces cerevisiae and other yeast, complex IV participates in the formation of supercomplexes with complex III, facilitating efficient electron transfer and potentially regulating reactive oxygen species production[2][3][7]. It is essential for aerobic respiration and cellular energy metabolism[2][5][6]. Due to evolutionary conservation, yeast complex IV is a model for studying bioenergetics and mitochondrial diseases[5][6].

Other names
Cytochrome c oxidaseComplex IVMitochondrial respiratory chain complex IVCIVCOXCytochrome aa3 oxidase
02

Mechanism of action

Inhibition of electron transfer (e.g., cyanide, azide, CO block oxygen reduction by binding to catalytic site); Blockade of oxygen binding (e.g., CO); Induction of oxidative stress by impairing electron flow; Inhibition of ATP production

03

Biological functions

Oxidative phosphorylationElectron transportCellular respirationATP productionProton translocation
04

Disease associations

Mitochondrial diseaseNeurodegenerative diseaseMetabolic diseaseAging (model organism role)Other (altered function contributes to cellular energy defects and oxidative stress)
05

Safety considerations

Inhibition causes mitochondrial dysfunction and cytotoxicityAccumulation of reactive oxygen speciesEnergy failure in eukaryotic cellsNon-specificity/toxicity of inhibitors prevents therapeutic use
06

Interacting drugs

Potassium cyanide

4 more in the full profile.

07

Biomarkers

Enzyme activity assays (cytochrome c oxidase activity)Oxygen consumption rates in yeastLevels of subunit proteins (e.g., Cox1, Cox2, Cox3)Mitochondrial membrane potential (as a functional readout)

Beyond the preview

Go deeper on Cytochrome c oxidase (yeast mitochondrial) (CIV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome c oxidase (yeast mitochondrial) (CIV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call